- Correspondence to: Dr S Olschwang, INSERM U434, 27 rue Juliette Dodu, 75010 Paris, France; .
- First published March 1, 2003.
Cancer risk in 348 French MSH2 or MLH1 gene carriers
Y Parc, C Boisson, G Thomas, and S Olschwang
Web-only Supplementary Tables
Table 1 PCR amplification and DGGE conditions
Table 2 MSH2 and MLH1 truncating mutations
Table 3 Missense variants with predicted biological consequence
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.